1990至2017年美国皮肤及皮下疾病负担研究
基于全球疾病负担(GBD)2017数据,分析1990至2017年美国50州及哥伦比亚特区皮肤及皮下疾病负担趋势与地理差异。年龄标化伤残调整寿命年(DALY)率从1990年821.6(95%UI 570.3-1124.9)升至2017年884.2(95%UI 614.0-1207.9),各州变化幅度不同。2017年纽约DALY率最高(1097.0),怀俄明最低(672.9);女性总体DALY率高于男性,但男性黑色素瘤和角质形成细胞癌DALY率更高。
要点
- 1990至2017年美国皮肤及皮下疾病年龄标化DALY率总体上升。
- 各州DALY率变化幅度存在地理差异,纽约增幅最大,科罗拉多等州最小。
- 男性黑色素瘤和角质形成细胞癌DALY率高于女性。
核心结论
- GBD数据显示美国皮肤及皮下疾病负担较大,DALY率趋势因州而异。
- 角质形成细胞癌的年龄标化DALY率在男性中似乎更高。
研究设计与样本
- GBD将皮肤疾病分为15个亚类,并估计黑色素瘤和角质形成细胞癌负担。
- 分析时间为2019年9月9日至2020年3月31日。
主要发现
- 1990年年龄标化DALY率为821.6(95%UI 570.3-1124.9),2017年为884.2(95%UI 614.0-1207.9)。
- 纽约百分比变化最大为0.12%(95%UI 0.09%-0.15%),科罗拉多、内华达、新墨西哥和犹他最小均为0.04%。
- 2017年纽约年龄标化DALY率最高为1097.0(95%UI 764.9-1496.1),怀俄明最低为672.9(95%UI 465.6-922.3)。
- 女性总体年龄标化DALY率为971.20(95%UI 676.76-1334.59),男性为799.23(95%UI 559.62-1091.50)。
- 男性黑色素瘤DALY率为80.82(95%UI 51.68-123.18),女性为42.74(95%UI 34.05-70.66);男性角质形成细胞癌DALY率为37.56(95%UI 29.35-49.52),女性为14.42(95%UI 10.01-20.66)。
临床怎么用
- 各州可利用这些数据针对性地制定干预措施以满足人群需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Skin and subcutaneous diseases affect the health of millions of individuals in the US. Data are needed that highlight the geographic trends and variations of skin disease burden across the country to guide health care decision-making. OBJECTIVE: To characterize trends and variations in the burden of skin and subcutaneous tissue diseases across the US from 1990 to 2017. DESIGN, SETTING, AND PARTICIPANTS: For this cohort study, data were obtained from the Global Burden of Disease (GBD), a study with an online database that incorporates current and previous epidemiological studies of disease burden, and from GBD 2017, which includes more than 90 000 data sources such as systematic reviews, surveys, population-based disease registries, hospital inpatient and outpatient data, cohort studies, and autopsy data. The GBD separated skin conditions into 15 subcategories according to incidence, prevalence, adequacy of data, and standardized disease definitions. GBD 2017 also estimated the burden from melanoma of the skin and keratinocyte carcinoma. Data analysis for the present study was conducted from September 9, 2019, to March 31, 2020. MAIN OUTCOMES AND MEASURES: Primary study outcomes included age-standardized disability-adjusted life-years (DALYs), incidence, and prevalence. The data were stratified by US states with the highest and lowest age-standardized DALY rate per 100 000 people, incidence, and prevalence of each skin condition. The percentage change in DALY rates in each state was calculated from 1990 to 2017. RESULTS: Overall, age-standardized DALY rates for skin and subcutaneous diseases increased from 1990 (821.6; 95% uncertainty interval [UI], 570.3-1124.9) to 2017 (884.2; 95% UI, 614.0-1207.9) in all 50 states and the District of Columbia. The degree of increase varied according to geographic location, with the largest percentage change of 0.12% (95% UI, 0.09%-0.15%) in New York and the smallest percentage change of 0.04% (95% UI, 0.02%-0.07%) in Colorado, 0.04% (95% UI, 0.01%-0.06%) in Nevada, 0.04% (95% UI, 0.02%-0.07%) in New Mexico, and 0.04% (95% UI, 0.02%-0.07%) in Utah. The age-standardized DALY rate, incidence, and prevalence of specific skin conditions differed among the states. New York had the highest age-standardized DALY rate for skin and subcutaneous disease in 2017 (1097.0 [95% UI, 764.9-1496.1]), whereas Wyoming had the lowest age-standardized DALY rate (672.9 [95% UI, 465.6-922.3]). In all 50 states and the District of Columbia, women had higher age-standardized DALY rates for overall skin and subcutaneous diseases than men (women: 971.20 [95% UI, 676.76-1334.59] vs men: 799.23 [95% UI, 559.62-1091.50]). However, men had higher DALY rates than women for malignant melanoma (men: 80.82 [95% UI, 51.68-123.18] vs women: 42.74 [95% UI, 34.05-70.66]) and keratinocyte carcinomas (men: 37.56 [95% UI, 29.35-49.52] vs women: 14.42 [95% UI, 10.01-20.66]). CONCLUSIONS AND RELEVANCE: Data from the GBD suggest that the burden of skin and subcutaneous disease was large and that DALY rate trends varied across the US; the age-standardized DALY rate for keratinocyte carcinoma appeared greater in men. These findings can be used by states to target interventions and meet the needs of their population.
引用
- Laughter MR, Maymone MBC, Karimkhani C, et al. The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017. JAMA Dermatol. 2020. PMID: 32520352. doi:10.1001/jamadermatol.2020.1573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。